NNC 0128-0000-2011

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Congenital Bleeding DisorderHaemophilia AHaemophilia B

Phase 1

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

CompletedNCT01272206

Novo Nordisk A/SCongenital Bleeding Disorder, Haemophilia A, Haemophilia B

Start: 2011-01-31End: 2011-03-31Updated: 2014-08-20

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

CompletedNCT01288391

Novo Nordisk A/SCongenital Bleeding Disorder, Haemophilia A, Haemophilia B

Start: 2011-01-31End: 2011-07-31Updated: 2016-05-13